Piper Jaffray Maintains Jazz Pharmaceuticals at Overweight, Raises PT from $64 to $68
Tickers: JAZZ
Get News First. Profit Faster
With Benzinga Professional get unlimited access to ALL content! PLUS:
- REALTIME NEWSFEED
- REALTIME AUDIO NEWS
- FULL CALENDAR SUITE
- CHAT WITH OUR NEWS DESK
RECENT PRO ALERTS
FDA Says Valeant's, Glaxo's Potiga Linked to Retinal Abnormalities
04:59pm - April 26, 2013Facebook's James Breyer Won't Stand for Re-Election
04:55pm - April 26, 2013S&P Downgrades Barrick Gold from BBB+ to BBB; Outlook Negative
04:49pm - April 26, 2013
Posted in: Price Target, Analyst Ratings
Partner Network